|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
27.380 +0.740 (+2.778%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,292,636 | -7.478% | 1,397,112 | 1,305,707 | 956,267 | 845,874 |
| Cost of Sales | (386,361) | -6.635% | (413,817) | (379,291) | (289,484) | (216,790) |
| Gross Profit | 906,275 | -7.833% | 983,295 | 926,416 | 666,783 | 629,084 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,166) | -- | 473 | (4,594) | (8,615) | (2,932) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (62) | -- | 305 | 326 | 1,501 | 119 | |
| Profit / (Loss) before Taxation | 235,630 | -10.233% | 262,492 | 249,797 | 97,427 | 274,268 | |
| Taxation | (33,965) | -24.243% | (44,834) | (41,110) | (23,337) | (37,332) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,400 | -46.667% | 17,625 | (3,452) | (3,060) | (5,913) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 211,065 | -10.293% | 235,283 | 205,235 | 71,030 | 231,023 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (27,392) | -6.307% | (29,236) | (35,438) | (40,723) | (49,314) |
| Depreciation & Amortisation | 103,339 | 4.836% | 98,572 | 101,774 | 96,839 | 64,306 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 91.000 | -9.901% | 101.000 | 86.000 | 29.286 | 93.571 |
| DPS (cts) | 40.000 | -- | 40.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 43.956% | -- | 39.604% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 24.468 | -- | 25.433 | 23.810 | 22.504315 | 22.960439 |
| Remarks: | Real time quote last updated: 22/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 211,065 |
| %Change | -10.293% |
| EPS / (LPS) | RMB 0.910 |
| NBV Per Share (¥) | RMB 24.468 |